Kazuaki Sakai

Safety and Pharmacokinetics of Urtoxazumab, a Humanized Monoclonal Antibody, against Shiga-Like Toxin 2 in Healthy Adults and in Pediatric Patients Infected with Shiga-Like Toxin-Producing <i>Escherichia coli</i>

Eduardo López, María M Contrini, Eduardo Glatstein et al. · Antimicrobial Agents and Chemotherapy · 2009 · 101 citations · Full text

Microbial Toxin, Allergy, Health Sciences +13

An Epidemiologic Surveillance of Shiga-like Toxin-producing Escherichia coli Infection in Argentinean Children

Eduardo López, María M Contrini, Eduardo Glatstein et al. · The Pediatric Infectious Disease Journal · 2011 · 50 citations

Proposed Selection Strategy of Surrogate Matrix to Quantify Endogenous Substances by Japan Bioanalysis Forum DG2015-15

Akira Wakamatsu, Shoko Ochiai, Eiko Suzuki et al. · Bioanalysis · 2018 · 35 citations · Full text

Bioconcentration, Blank Matrix, Surrogate Matrix +23

CYP1A1, GSTM1, GSTT1 and TP53 Polymorphisms and Risk of Gallbladder Cancer in Bolivians

Kazuaki Sakai, Ernesto Loza, Guido Villa-Gomez Roig et al. · Asian Pacific Journal of Cancer Prevention · 2016 · 13 citations · Full text

Healthy Subjects, Genetic Epidemiology, Gastroenterology +16